Anthropic wants to develop its own drugs
The Verge
AI company Anthropic is launching a scientific workbench tool and plans to begin developing its own treatments for neglected diseases.Summary
Anthropic has introduced Claude Science, an AI workbench designed to assist scientists with data analysis and visualization. Beyond selling software tools to pharmaceutical firms, the company aims to develop its own drugs, specifically targeting neglected diseases. While AI is increasingly integrated into drug discovery to identify potential molecules and research pathways, experts emphasize that human supervision remains essential and the physical testing process for safety and efficacy remains a time-consuming, expensive, and necessary hurdle.
(Source：The Verge)